Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
The rise in incidence of antimicrobial resistance, consumer demands and improved understanding of antimicrobial action has encouraged international agencies to review the use of antimicrobial drugs. More detailed understanding of relationships between the pharmacokinetics (PK) of antimicrobial drugs in target animal species and their action on target pathogens [pharmacodynamics (PD)] has led to greater sophistication in design of dosage schedules which improve the activity and reduce the selection pressure for resistance in antimicrobial therapy. This, in turn, may be informative in the pharmaceutical development of antimicrobial drugs and in their selection and clinical utility. PK/PD relationships between area under the concentration time curve from zero to 24 h (AUC0‐‐24) and minimum inhibitory concentration (MIC), maximum plasma concentration (Cmax) and MIC and time during which plasma concentrations exceed the MIC have been particularly useful in optimizing efficacy and minimizing resistance. Antimicrobial drugs have been classified as concentration‐dependent where increasing concentrations at the locus of infection improve bacterial kill, or time‐dependent where exceeding the MIC for a prolonged percentage of the inter‐dosing interval correlates with improved efficacy. For the latter group increasing the absolute concentration obtained above a threshold does not improve efficacy. The PK/PD relationship for each group of antimicrobial drugs is ‘bug and drug’ specific, although ratios of 125 for AUC0‐‐24:MIC and 10 for Cmax:MIC have been recommended to achieve high efficacy for concentration‐dependent antimicrobial drugs, and exceeding MIC by 1–5 multiples for between 40 and 100% of the inter‐dosing interval is appropriate for most time‐dependent agents. Fluoroquinolones, aminoglycosides and metronidazole are concentration‐dependent and beta‐lactams, macrolides, lincosamides and glycopeptides are time‐dependent. For drugs of other classes there is limited and conflicting information on their classification. Resistance selection may be reduced for concentration‐dependent antimicrobials by achieving an AUC0‐‐24:MIC ratio of greater than 100 or a Cmax:MIC ratio of greater than 8. The relationships between time greater than MIC and resistance selection for time‐dependent antimicrobials have not been well characterized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908 · cited 4×
“Alternatively it may be dependent on maintaining concentrations in plasma just above the MIC for a prolonged time (Craig, 1998a) and, for some drugs and pathogens, a combination of concentration and time of exposure may be important (co-dependency).”
BackgroundInfluentialGoodman and Gilman's The Pharmacological Basis of Therapeutics
Hastings, R. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540120077042 · Cited by 2,371
Moore, R. D., Lietman, P. S., & Smith, C. R. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.1.93 · Cited by 1,139
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Antimicrobial Therapy in Veterinary Medicine
(2001) · Journal of Equine Veterinary Science · doi:10.1016/s0737-0806(01)70241-9 · Cited by 840
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model
Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S., & Craig, W. A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.831 · Cited by 720
Quinolone-Resistant Campylobacter jejuni Infections in Minnesota, 1992–1998
Smith, K. E., Besser, J. M., Hedberg, C. W., Leano, F. T., Bender, J. B., Wicklund, J. H., Johnson, B. P., Moore, K. A., & Osterholm, M. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905203402001 · Cited by 666
Craig, W. A. (1995) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(95)00053-d · Cited by 618
Pharmacodynamics of Levofloxacin: A New Paradigm for Early Clinical Trials
Preston, S. L. (1998) · JAMA · doi:10.1001/jama.279.2.125 · Cited by 589
The pharmacokinetics of Norpace.
Karim, A. (1975) · PubMed · Cited by 552
Thomas, J. K., Forrest, A., Bhavnani, S. M., Hyatt, J. M., Cheng, A., Ballow, C. H., & Schentag, J. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.521 · Cited by 507
Blaser, J., Stone, B. B., Groner, M. C., & Zinner, S. H. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.7.1054 · Cited by 481
Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
CRAIG, W. A., & ANDES, D. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199603000-00015 · Cited by 435
Drusano, G. L., Johnson, D. E., Rosen, M., & Standiford, H. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.483 · Cited by 426
Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man
Bates, J., Jordens, J. Z., & Griffiths, D. T. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.4.507 · Cited by 420
Quinolone Antimicrobial Agents
Neu, H. C. (1992) · Annual Review of Medicine · doi:10.1146/annurev.me.43.020192.002341 · Cited by 400
The pharmacokinetic–pharmacodynamic approach to a rational dosage regimen for antibiotics
Toutain, P. L., del Castillo, J. R. E., & Bousquet-Mélou, A. (2002) · Research in Veterinary Science · doi:10.1016/s0034-5288(02)00039-5 · Cited by 384
Hyatt, J. M., McKinnon, P. S., Zimmer, G. S., & Schentag, J. J. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199528020-00005 · Cited by 374
Sáenz, Y., Zarazaga, M., Lantero, M., Gastañares, M. J., Baquero, F., & Torres, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.267-271.2000 · Cited by 358
Leggett, J. E., Fantin, B., Ebert, S., Totsuka, K., Vogelman, B., Calame, W., Mattie, H., & Craig, W. A. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.2.281 · Cited by 354
Population Pharmacokinetics/Dynamics*
Sheiner, L. B., & Ludden, T. M. (1992) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.32.040192.001153 · Cited by 316
Blondeau, J. M., Zhao, X., Hansen, G., & Drlica, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.433-438.2001 · Cited by 314
The Nephrotoxicity of Antimicrobial Agents
Appel, G. B., & Neu, H. C. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703312961305 · Cited by 310
Klare, I., Heier, H., Claus, H., BÖHME, G., Marin, S., Seltmann, G., Hakenbeck, R., Antanassova, V., & Witte, W. (1995) · Microbial Drug Resistance · doi:10.1089/mdr.1995.1.265 · Cited by 262
Antibiotic Pharmacodynamics in Cerebrospinal Fluid
Lutsar, I., McCracken, Jr., & Friedland, I. R. (1998) · Clinical Infectious Diseases · doi:10.1086/515003 · Cited by 242
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections
Craig, W. A., Redington, J., & Ebert, S. C. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.suppl_c.29 · Cited by 238
THE MULTIPLE NATURE OF THE ANIMAL PROTEIN FACTOR
Stokstad, E. L. R., Jukes, T. H., Pierce, J., Page, A. C., & Franklin, A. L. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)56683-7 · Cited by 234
Marchant, C. D., Carlin, S. A., Johnson, C. E., & Shurin, P. A. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80601-8 · Cited by 229
Lacy, M. K., Lu, W., Xu, X., Tessier, P. R., Nicolau, D. P., Quintiliani, R., & Nightingale, C. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.672 · Cited by 219
Further Observations on the "Animal Protein Factor"
Stokstad, E. L. R., & Jukes, T. H. (1950) · Experimental Biology and Medicine · doi:10.3181/00379727-73-17731 · Cited by 201
Rodvold, K. A., Gotfried, M. H., Danziger, L. H., & Servi, R. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1399 · Cited by 200
Effect of schedule of administration on the therapeutic efficacy of penicillin
Eagle, H., Fleischman, R., & Musselman, A. D. (1950) · The American Journal of Medicine · doi:10.1016/0002-9343(50)90425-6 · Cited by 197
Antimicrobial resistance in livestock
Catry, B., Laevens, H., Devriese, L. A., OPSOMER, G., & de Kruif, A. (2003) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1046/j.1365-2885.2003.00463.x · Cited by 189
Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin
Patel, K. B., Xuan, D., Tessier, P. R., Russomanno, J. H., Quintiliani, R., & Nightingale, C. H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2375 · Cited by 172
Madaras‐Kelly, K., Ostergaard, B. E., Hovde, L. B., & Rotschafer, J. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.627 · Cited by 170
Forrest, A., Chodosh, S., Amantea, M., Collins, D. A., & Schentag, J. J. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.suppl_1.45 · Cited by 137
What Do We Really Know About Antibiotic Pharmacodynamics?
Gunderson, B. W., Ross, G. H., Ibrahim, K. H., & Rotschafer, J. C. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.18.302s.33905 · Cited by 124
Knudsen, J. D., Fuursted, K., Raber, S. R., Espersen, F., & Frimodt‐Møller, N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1247-1254.2000 · Cited by 115
Alteration of effectiveness of antibiotics by anaerobiosis.
Rm, V., & Gl, M. (1977) · PubMed · Cited by 108
Larsson, A. J., Walker, K. J., Raddatz, J. K., & Rotschafer, J. C. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.4.589 · Cited by 105
Roosendaal, R., Bakker‐Woudenberg, I. A. J. M., Raffe, M. V. D. B.-V., & MICHEL, M. F. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.3.403 · Cited by 101
Clinical Pharmacology of the Fluoroquinolones: Studies in Human Dynamic/Kinetic Models
Schentag, J. J. (2000) · Clinical Infectious Diseases · doi:10.1086/314059 · Cited by 96
Strategies to minimize the development of antibiotic resistance.
Baquero, F., & Negri, M. C. (1997) · PubMed · Cited by 95
Frimodt-Meller, N., Bentzen, M. W., & Thomsen, V. F. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/154.3.511 · Cited by 88
Hyatt, J. M., Nix, D. E., & Schentag, J. J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.12.2730 · Cited by 86
Role of Population Pharmacokinetics in Drug Development
Samara, E. E., & Granneman, R. G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732040-00003 · Cited by 78
Deziel-Evans, L., Murphy, J. E., & Ml, J. (1986) · PubMed · Cited by 78
Pharmacological Basis Of Large Animal Medicine
Bogan, J. A., Lees, P., & YOXALL, A. T. (1983) · Cited by 75
Clinical Significance of Antibiotic Tissue Penetration
Schentag, J. J. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198900161-00005 · Cited by 75
In-vitro evaluation of ampicillin/brobactam and comparison with other β-lactam antibiotics
Melchior, N. H., & Keiding, J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.1.29 · Cited by 71
Baquero, F., Negri, M. C., Morosini, M.-I., & Blázquez, J. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515358.ch7 · Cited by 60
Corvaisier, S., Maire, P. H., dʼYvoire, M. J. Y. B., Barbaut, X., Bleyzac, N., & Jelliffe, R. W. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1731 · Cited by 54
Lavoie, G. Y., & Bergeron, M. G. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.3.404 · Cited by 46
Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis
Nix, D. E., Tyrrell, R. M., & Müller, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1848 · Cited by 38
White, C. A., Toothaker, R. D., Smith, A. L., & Slattery, J. T. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.7.1046 · Cited by 37
(2002) · CRC Press eBooks · doi:10.1201/9781420024128.ch2 · Cited by 19
Metadata
- Authors
- MCKELLAR, Q. A., SANCHEZ BRUNI, S. F., & JONES, D. G.
- Venue
- Journal of Veterinary Pharmacology and Therapeutics
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 27
- Issue
- 6
- Pages
- 503-514
- ISSN
- 0140-7783 (ISSN-L)
- 1365-2885
- OpenAlex
- W2120135710
- Cited by
- 302
- References
- 56
- FWCI
- 6.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.